Delphinus Medical Technologies is a leading medical imaging company based in Detroit, MI. Their innovative SoftVue 3D Whole Breast Ultrasound Tomography system is FDA PMA approved for dense breast screening, providing a transformative approach to breast cancer detection. By combining mammography with SoftVue, the system increases cancer detection by 20% compared to mammography alone, offering a unique and effective solution for women with dense breasts.
With over 2,000 transducer elements and TriAD triple acoustic detection, SoftVue delivers unrivaled imaging capabilities, capturing both reflected echoes and transmission signals passing through the breast tissue. This advanced technology allows physicians to distinguish between normal tissue and areas of concern, improving both sensitivity and specificity in breast cancer screening. Delphinus Medical Technologies is dedicated to revolutionizing women's health and enhancing the accuracy of mammograms through their groundbreaking ultrasound tomography system.
Generated from the website